A human trial to evaluate the efficacy and safety of Rhus verniciflua Stokes and Eucommia ulmoides Oliver extract mixtures on improvement of Liver functio
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0004552
- Lead Sponsor
- Woosuk University Korean Medicine Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
1)Males and females aged 19-70 years at the screening examination
2)Participants with 45=Alanine Transaminase(ALT)=135 (U/L)
3)Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
1)Patients with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
2)Patients who take medicine for improvement of liver function and intake health functional food within a month prior to the screening examination
3)Patients with a history of antipsychotic medication use within 3 months prior to the screening examination
4)Patients with a history of clinically significant hypersensitivity reactions to drugs and test products
5)Patients who have participated in other clinical trials within 3 months prior to the screening examination
6)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT (Alanine Transaminase);GGT (Gamma-glutamyl transferase)
- Secondary Outcome Measures
Name Time Method liver function index;Lipids Metabolism index;steatosis index;Antioxidant index;MFS(Multidimensional Fatigue Scale)